GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (OTCPK:XVIPF) » Definitions » E10

Xvivo Perfusion AB (Xvivo Perfusion AB) E10 : $0.04 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Xvivo Perfusion AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Xvivo Perfusion AB's adjusted earnings per share data for the three months ended in Mar. 2024 was $0.069. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.04 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Xvivo Perfusion AB's average E10 Growth Rate was 161.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-17), Xvivo Perfusion AB's current stock price is $37.09. Xvivo Perfusion AB's E10 for the quarter that ended in Mar. 2024 was $0.04. Xvivo Perfusion AB's Shiller PE Ratio of today is 927.25.

During the past 12 years, the highest Shiller PE Ratio of Xvivo Perfusion AB was 1814.29. The lowest was 595.74. And the median was 1444.74.


Xvivo Perfusion AB E10 Historical Data

The historical data trend for Xvivo Perfusion AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB E10 Chart

Xvivo Perfusion AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.02 0.03

Xvivo Perfusion AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.03 0.04

Competitive Comparison of Xvivo Perfusion AB's E10

For the Medical Devices subindustry, Xvivo Perfusion AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xvivo Perfusion AB's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Xvivo Perfusion AB's Shiller PE Ratio falls into.



Xvivo Perfusion AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Xvivo Perfusion AB's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.069/132.2054*132.2054
=0.069

Current CPI (Mar. 2024) = 132.2054.

Xvivo Perfusion AB Quarterly Data

per share eps CPI Adj_EPS
201406 0.006 100.432 0.008
201409 0.010 100.161 0.013
201412 0.007 100.225 0.009
201503 0.000 99.950 0.000
201506 0.006 99.995 0.008
201509 0.007 100.228 0.009
201512 0.015 100.276 0.020
201603 0.006 100.751 0.008
201606 0.008 101.019 0.010
201609 -0.002 101.138 -0.003
201612 -0.002 102.022 -0.003
201703 0.000 102.022 0.000
201706 0.005 102.752 0.006
201709 -0.001 103.279 -0.001
201712 0.025 103.793 0.032
201803 0.018 103.962 0.023
201806 0.017 104.875 0.021
201809 0.000 105.679 0.000
201812 0.020 105.912 0.025
201903 -0.001 105.886 -0.001
201906 0.009 106.742 0.011
201909 0.019 107.214 0.023
201912 -0.008 107.766 -0.010
202003 0.025 106.563 0.031
202006 -0.064 107.498 -0.079
202009 -0.058 107.635 -0.071
202012 -0.084 108.296 -0.103
202103 0.023 108.360 0.028
202106 -0.037 108.928 -0.045
202109 -0.005 110.338 -0.006
202112 0.046 112.486 0.054
202203 0.017 114.825 0.020
202206 0.026 118.384 0.029
202209 0.016 122.296 0.017
202212 0.002 126.365 0.002
202303 0.046 127.042 0.048
202306 0.021 129.407 0.021
202309 0.007 130.224 0.007
202312 0.223 131.912 0.223
202403 0.069 132.205 0.069

Add all the adjusted EPS together and divide 10 will get our e10.


Xvivo Perfusion AB  (OTCPK:XVIPF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Xvivo Perfusion AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=37.09/0.04
=927.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Shiller P/E Ratio of Xvivo Perfusion AB was 1814.29. The lowest was 595.74. And the median was 1444.74.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Xvivo Perfusion AB E10 Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Xvivo Perfusion AB (Xvivo Perfusion AB) Business Description

Traded in Other Exchanges
Address
Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.